Variant report
Variant | nsv1016543 |
---|---|
Chromosome Location | chr7:118626169-118660614 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:13)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:118629006..118631002-chr7:118732998..118734533,2 | K562 | blood: | |
2 | chr7:118637455..118639784-chr7:118654717..118656624,2 | K562 | blood: | |
3 | chr7:118646033..118648474-chr7:118650936..118653090,2 | K562 | blood: | |
4 | chr7:118646033..118648474-chr7:118650936..118653090,2 | K562 | blood: | |
5 | chr7:118654140..118657090-chr7:118659038..118660634,2 | K562 | blood: | |
6 | chr7:118611978..118614798-chr7:118654699..118657373,2 | K562 | blood: | |
7 | chr7:118635764..118637617-chr7:118641365..118644121,2 | MCF-7 | breast: | |
8 | chr7:118658923..118660731-chr7:118674082..118677043,2 | K562 | blood: | |
9 | chr7:118637455..118640247-chr7:118654338..118656624,3 | K562 | blood: | |
10 | chr7:118635764..118637617-chr7:118641365..118644121,2 | MCF-7 | breast: | |
11 | chr7:118637455..118640247-chr7:118654338..118656624,3 | K562 | blood: | |
12 | chr7:118654140..118657090-chr7:118659038..118660634,2 | K562 | blood: | |
13 | chr7:118637455..118639784-chr7:118654717..118656624,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535321080 | chr7:118635002-118635003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540120774 | chr7:118635003-118635004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185183432 | chr7:118635049-118635050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115804150 | chr7:118635050-118635051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545788604 | chr7:118635098-118635099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562680482 | chr7:118635115-118635116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10480733 | chr7:118635119-118635120 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs148681356 | chr7:118635129-118635130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190041145 | chr7:118635181-118635182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528006344 | chr7:118635255-118635256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375529227 | chr7:118635351-118635352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11975840 | chr7:118635402-118635403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73719612 | chr7:118635414-118635415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566478865 | chr7:118635444-118635445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7787447 | chr7:118635459-118635460 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs182578189 | chr7:118635482-118635483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs371822662 | chr7:118635506-118635507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569008172 | chr7:118635512-118635513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12534310 | chr7:118635554-118635555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7788041 | chr7:118635574-118635575 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs574506283 | chr7:118635578-118635579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs79217744 | chr7:118635652-118635653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553695882 | chr7:118635674-118635675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576715944 | chr7:118635690-118635691 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545824293 | chr7:118635773-118635774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562519763 | chr7:118635833-118635834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576505577 | chr7:118635835-118635836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555860801 | chr7:118635904-118635905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115469731 | chr7:118635923-118635924 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575697579 | chr7:118636000-118636001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs367662875 | chr7:118636023-118636024 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547966898 | chr7:118636060-118636061 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116940457 | chr7:118636082-118636083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10953887 | chr7:118636083-118636084 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs552223682 | chr7:118636095-118636096 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568835297 | chr7:118636165-118636166 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187270968 | chr7:118636185-118636186 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs202171081 | chr7:118636197-118636198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547929094 | chr7:118636198-118636199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10275658 | chr7:118636210-118636211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150603225 | chr7:118636214-118636215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191584102 | chr7:118636223-118636224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141813363 | chr7:118636309-118636310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576753383 | chr7:118636317-118636318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539321874 | chr7:118636362-118636363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140724760 | chr7:118636414-118636415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576320314 | chr7:118636460-118636461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs370395893 | chr7:118636478-118636479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs75927770 | chr7:118636481-118636482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74812736 | chr7:118636482-118636483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Schizophrenia | 21346763 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:118635000-118636200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr7:118635200-118635600 | Enhancers | Fetal Lung | lung |
3 | chr7:118635600-118637000 | Weak transcription | Fetal Lung | lung |
4 | chr7:118637000-118637600 | Enhancers | Fetal Lung | lung |
5 | chr7:118637600-118639000 | Weak transcription | Fetal Lung | lung |
6 | chr7:118639000-118639400 | Flanking Active TSS | Fetal Lung | lung |
7 | chr7:118639400-118640200 | Enhancers | Fetal Lung | lung |
8 | chr7:118639800-118640400 | Enhancers | Fetal Brain Male | brain |
9 | chr7:118646600-118647800 | Enhancers | Fetal Brain Male | brain |
10 | chr7:118646600-118648400 | Enhancers | Fetal Lung | lung |
11 | chr7:118656800-118657800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr7:118657000-118657200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr7:118657000-118657600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr7:118657000-118657800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr7:118657000-118657800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr7:118657200-118657600 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
17 | chr7:118657200-118657800 | Enhancers | H9 Cell Line | embryonic stem cell |
18 | chr7:118657200-118657800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr7:118657200-118657800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr7:118657200-118657800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
21 | chr7:118657400-118657800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr7:118657600-118657800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
23 | chr7:118657800-118666400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |